Skip to content

Latest

HDA issues statement on drug shortages

HDA issues statement on drug shortages

Healthcare Distribution Alliance (HDA) president and CEO Chip Davis released the following statement in response to the Senate Finance Committee’s hearing on “Examining Supply Challenges, Impacts, and Policy Solutions from a Federal Health Program Perspective.

Lilly’s Omvoh now available in the U.S. for ulcerative colitis

Lilly’s Omvoh now available in the U.S. for ulcerative colitis

The Food and Drug Administration has approved Eli Lilly and Co.’s Omvoh (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), as the first and only interleukin-23p19 (IL-23p19) antagonist for the treatment of moderately to severely active ulcerative colitis (UC) in adults.

Dial gives back to teachers

Dial gives back to teachers

Dial continues to acknowledge the pivotal role that teachers play in inspiring and shaping the future generation through its long-standing support of healthy handwashing education. As the No.

Video Forum: Health Equity Summit, Part 2

Video Forum: Health Equity Summit, Part 2

  In this week’s Video Forum, Kearney’s Laura Bowen and Karen Yocky talk about what the consulting firm has learned from its work in helping clients step up the fight against health disparities. They spoke during the second annual Health Equity Summit sponsored by Kearney and Chain Drug Review.